Clal Insurance Enterprises Holdings Ltd Buys 174,000 Shares of SPDR S&P Biotech ETF $XBI

Clal Insurance Enterprises Holdings Ltd raised its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 68.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 428,000 shares of the exchange traded fund’s stock after purchasing an additional 174,000 shares during the period. Clal Insurance Enterprises Holdings Ltd owned 0.79% of SPDR S&P Biotech ETF worth $35,494,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. DHJJ Financial Advisors Ltd. acquired a new position in SPDR S&P Biotech ETF in the 2nd quarter valued at $25,000. Garrison Bradford & Associates Inc. acquired a new position in SPDR S&P Biotech ETF during the 1st quarter worth $39,000. Quaker Wealth Management LLC boosted its holdings in SPDR S&P Biotech ETF by 101.2% during the second quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock valued at $52,000 after acquiring an additional 53,536 shares during the period. Avalon Trust Co acquired a new stake in shares of SPDR S&P Biotech ETF in the first quarter valued at about $57,000. Finally, Curio Wealth LLC grew its position in shares of SPDR S&P Biotech ETF by 74,700.0% in the second quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock valued at $62,000 after purchasing an additional 747 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $115.18 on Wednesday. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $116.18. The stock has a market capitalization of $6.99 billion, a PE ratio of 11.47 and a beta of 0.93. The stock has a 50-day simple moving average of $105.00 and a 200 day simple moving average of $92.05.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.